Three-year results of combined microstent and canaloplasty surgery
Part of Eyes & vision clinical trials.
This trial is checking how well a combined eye surgery (Hydrus microstent plus canaloplasty plus cataract surgery) works over 3 years. It looks at long-term safety and effect on eye pressure. It's for people with open-angle glaucoma who already had that specific combination of procedures.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You had open-angle glaucoma (mild, moderate, or severe) at the time of surgery.
- You had a combined procedure with a Hydrus microstent, a 360-degree canaloplasty, and cataract surgery at least 3 years ago.
- You have not had a prior corneal transplant, refractive eye surgery, retinal surgery, or any previous glaucoma surgery (including MIGS or traditional glaucoma procedures).
- You do not have angle-closure glaucoma or other types of secondary glaucoma.
- Prior selective laser trabeculoplasty (SLT) is allowed.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares two different devices (MINIject® and Hydrus® Microstent) used in microinvasive glaucoma surgery, both done at the same time as cataract surgery. It aims to find which one works better at lowering eye pressure.
This study compares two procedures done during cataract surgery: placing a tiny stent (Hydrus Microstent) or performing a goniotomy (a small cut in the eye's drainage tissue). Both aim to lower eye pressure in people with mild to moderate open-angle glaucoma.
This study looks at whether two types of tiny drainage stents (PreserFlo and XEN) work safely to lower eye pressure in glaucoma. Some patients will also receive an amniotic membrane (a thin tissue that helps healing) during the surgery, and researchers will compare outcomes.
This trial studies outcomes after certain minimally invasive glaucoma surgeries, including the Preserflo microshunt. It may help improve how safely and effectively glaucoma surgery is done, and how patients are followed afterward.
This study compares a glaucoma drainage device approach to see which one better prevents loss of corneal cells after surgery. You may benefit by receiving close monitoring around the time of glaucoma surgery and helping doctors improve surgical choices.
This trial tests a small stent to help drain fluid from the eye and lower pressure in people who have both open-angle glaucoma and cataracts. The stent is placed during routine cataract surgery.
Hear when a new Glaucoma, Open-Angle trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.